Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Palatal perforation: A visible or non-visible deformity in leprosy

Gurung D, Gurung P. Comprehensive Publications. International Journal of Research in Medical Science. 2026; 8 (8) : 12 - 18.
Download PDF
Publication

Lepromatous Leprosy With Erythema Nodosum Leprosum

Farhoud N, Bhadbhade P. American College of Physicians. Annals of Internal Medicine: Clinical Cases. 2026; 5 (8) : 1 - 2.
Download PDF
Publication

Amitriptyline for neuropathic pain in patients with leprosy: a bicenter randomized controlled trial

Júnior J, Kubota G, Moreira L, et al. Pain. 2026; 167 (8) : 1810 - 1823.
Download PDF
Publication

Factors associated with disability among patients with leprosy: a scoping review

Masala CW, Haroen H, Pramukti I. Springer Science and Business Media LLC. BMC Infectious Diseases. 2026;
Download PDF
Publication

Infiltrated and Nodular Ear Pinna in a Case of Lepromatous Leprosy

Tyagi S, Sihag Y. Journal of cutaneous medicine and surgery. 2026;
Publication

Playful approach to Hansen's disease through an educational comic book

Quandt D, Vendruscolo C, Griboggi I, et al. Revista brasileira de enfermagem. 2026;
Download PDF
Publication

Leprosy Self-Care Health Management: A Quasi-Experimental Study for Assessing the Quality of Life and Stigma in People Affected by Leprosy in Rural Areas, Indonesia

Susanto T, Ati NAL, Rasni H, et al. Maad Rayan Publishing Company. Epidemiology and Health System Journal. 2026; 13 (1) : 22 - 34.
Download PDF
Publication

Peripheral nerve biopsy in pure neural leprosy: a 26-year experience in Brazil

Siquara-de-Sousa A, Hacker M, Vital R, et al. Brain communications. 2026; 8 (4) : 1 - 8.
Download PDF
Publication

Ultrasound and Magnetic Resonance Imaging in Evaluating the Peripheral Nerves in Patients with Clinically Detected Leprosy Having Peripheral Neuropathy

Dr. M Vinod Kumar , Dr. T Arul Dasan , Dr. Sirish Shivaramaiah . Journal of Surgical Radiology. 2026; 5 (6) : 587 - 601.
Download PDF
Publication

Fear of clofazimine-induced skin discoloration as a barrier to leprosy treatment: urgent need for alternative therapeutic options

Utami NN, Muchtar SV, Krismawati H, et al. Oxford University Press (OUP). Clinical and Experimental Dermatology. 2026;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 2
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD